MetLife director granted 587 deferred shares

MetLife Inc director Christian Stephane Mumenthaler received an award of 587 shares of MetLife common stock on June 16, 2026, valued at $87.40 per share.

Rhea-AI Filing Summary

MetLife Inc director Christian Stephane Mumenthaler received an award of 587 shares of MetLife common stock on June 16, 2026, valued at $87.40 per share. This grant is part of non-management director retainer fees and was elected to be deferred under MetLife’s Deferred Compensation Plan for Non-Management Directors.

Following this compensation-related acquisition, Mumenthaler directly holds 3,452 shares of MetLife common stock credited to his account.

Insider Trade Summary

Grant/Award: 587 shares

Grant/Award 1 txn

Insider Mumenthaler Christian Stephane

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$87.40	$51K

Holdings After Transaction: Common Stock — 3,452 shares (Direct)

Footnotes (1)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Key Figures

Stock grant size: 587 shares Grant price per share: $87.40 per share Total shares after transaction: 3,452 shares

3 metrics

Stock grant size 587 shares Common Stock award on June 16, 2026

Grant price per share $87.40 per share Value used for the 587-share award

Total shares after transaction 3,452 shares Director’s direct MetLife holdings following grant

Key Terms

non-management director retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors, Grant, award, or other acquisition

3 terms

non-management director retainer fees financial

"non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock"

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MetLife (MET) report for Christian Stephane Mumenthaler?

MetLife reported that director Christian Stephane Mumenthaler received an award of 587 shares of MetLife common stock as part of non-management director retainer fees, at a value of $87.40 per share, classified as a grant or other acquisition.

Was the MetLife (MET) Form 4 transaction an open-market purchase or a grant?

The Form 4 transaction for MetLife director Christian Stephane Mumenthaler was a stock grant or award, not an open-market purchase. It reflects non-management director retainer fees paid in MetLife common stock under the company’s director compensation arrangements.

How many MetLife (MET) shares does Christian Stephane Mumenthaler hold after this Form 4?

After receiving the 587-share award, Christian Stephane Mumenthaler holds a total of 3,452 shares of MetLife common stock directly. These holdings reflect his position following the compensation-related acquisition reported in the Form 4 filing.

How are MetLife (MET) non-management directors compensated according to this filing?

MetLife’s non-management director compensation arrangements pay a portion of director retainer fees in MetLife common stock. In this case, director Christian Stephane Mumenthaler received 587 shares as part of those fees, illustrating the equity-based component of director compensation.

Did Christian Stephane Mumenthaler defer his MetLife (MET) stock award?

Yes. The footnote states that Christian Stephane Mumenthaler elected to defer receipt of the 587 MetLife common shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the shares are credited according to the plan’s deferral terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:13 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mumenthaler Christian Stephane

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$87.4	3,452	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)